Personalised Cancer Vaccine Cuts Melanoma Death or Recurrence Risk by 42%October 23, 2026 Health 4 Views A major clinical trial shows a personalised mRNA vaccine combined with immunotherapy cuts the risk of death or melanoma recurrence by 42% in patients with advanced skin cancer.
